Prout Samantha Insider Trades

Insider Trading History

Track insider trading activity for Prout Samantha. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Accounting Officer
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$4.8M 330,973 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Accounting Officer
Holding Value $1.83M 125,951 shares
Last Trade
Jan 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$175k 12,240 shares
$14.27
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Accounting Officer
Holding Value $2M 138,191 shares
Last Trade
Jan 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$49.1k 3,443 shares
$14.27
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Accounting Officer
Holding Value $2.05M 141,634 shares
Last Trade
Dec 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$315k 32,193 shares
$9.80
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Accounting Officer
Holding Value $1.78M 122,941 shares
Last Trade
Feb 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$262k 27,416 shares
$9.57
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Accounting Officer
Holding Value $1.59M 109,441 shares
Last Trade
Feb 11, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$129k 13,500 shares
$9.57
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Accounting Officer
Holding Value $1.38M 95,525 shares
Last Trade
Jan 04, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$12.2k 1,297 shares
$9.41
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Accounting Officer
Holding Value $1.4M 96,822 shares
Last Trade
Jan 03, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$77.9k 8,275 shares
$9.41
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Accounting Officer
Holding Value $1.52M 105,097 shares
Last Trade
Jan 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$590k 62,715 shares
$9.41
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Accounting Officer
Holding Value $1.02M 70,483 shares
Last Trade
Jan 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$32.1k 3,443 shares
$9.31
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Accounting Officer
Holding Value $1.07M 73,926 shares
Last Trade
Apr 15, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$74.9k 7,027 shares
$10.66
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Accounting Officer
Holding Value $1.17M 80,953 shares
Last Trade
Jan 09, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$18.7k 1,337 shares
$14.00
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Accounting Officer
Holding Value $1.19M 82,290 shares
Last Trade
Jan 08, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$431k 30,767 shares
$14.00
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Accounting Officer
Holding Value $1.64M 113,057 shares
Last Trade
Jan 04, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$17.4k 1,296 shares
$13.44
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Accounting Officer
Holding Value $1.66M 114,353 shares
Last Trade
Jan 03, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$110k 8,142 shares
$13.53
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Accounting Officer
Holding Value $1.79M 123,808 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$621k 43,592 shares
$14.24
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Accounting Officer
Holding Value $1.77M 122,495 shares
Last Trade
Jan 02, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$18.7k 1,313 shares
$14.24
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Accounting Officer
Holding Value $1.43M 98,556 shares
Last Trade
Dec 31, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$331k 23,356 shares
$14.19
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Accounting Officer
Holding Value $1.77M 121,912 shares
Last Trade
Dec 26, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$107k 7,659 shares
$14.00
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Chief Accounting Officer
Holding Value $1.88M 129,571 shares
Last Trade
Aug 17, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$94.9k 7,432 shares
$12.77
$14.49

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up